Compare Fiserv Inc. Common Stock (FISV) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fiserv Inc. Common Stock vs Vaxcyte Inc. Common Stock — how do they compare? Fiserv Inc. Common Stock trades at $46.29 (market cap $24.81B), while Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B). The key difference: Fiserv Inc. Common Stock is far larger — about 2.4× Vaxcyte Inc. Common Stock's market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, Fiserv Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fiserv Inc. Common Stock for 0 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| FISV | PCVX | |
|---|---|---|
Market Cap | $24.81B | $10.51B |
Volume | 4,091,234 | 2,644,694 |
Sector | Technology | Health |
52-Week High | $126.54 | $73.82 |
52-Week Low | $44.36 | $40.32 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $52.60B | $9.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fiserv Inc. Common Stock
Fiserv, Inc. is a global provider of payments and financial services technology, offering merchant acquiring, digital commerce, and financial solutions through its Merchant Solutions and Financial Solutions segments.
Read more on FISV →About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →
